About University of Colorado Advanced Reproductive Medicine
University of Colorado Advanced Reproductive Medicine specializes in the evaluation and treatment of infertility and reproductive disorders. The center offers each patient a comprehensive evaluation and treatment plan to provide personalized care with the most advanced technology available. Our goal is to make every effort to treat reproductive disorders with simple methods and less expensive therapies. However, in cases where these prove unsuccessful, as a state of the art facility, Advanced Reproductive Medicine draws upon the latest advances and the most sophisticated methods available in infertility and reproductive therapy
Meet our doctors
The team is made up of nine physicians – Drs. Zane Al-Safi, Ruben Alvero, Serena Dovey, Shona Murray, Alex Polotsky, Lauren Roth and Nanette Santoro – who are board certified both in obstetrics and gynecology and the subspecialty of reproductive endocrinology and infertility, and one physician – Dr. Randall Meacham – who is subspecialty trained in male infertility. This team approach of both female and male infertility specialists offers the most comprehensive care for the treatment of infertility in one centralized location.
University of Colorado Advanced Reproductive Medicine is currently involved with numerous studies show-casing efforts in oncology-fertility, the preservation of human fertility during cancer treatments, and new contraceptive options.
1. LNG Contraceptive Patch
This study is looking at a new contraceptive patch which will offer women a contraceptive option that contains no estrogen, using a proven medication called Levonorgestrel.
2. Oncofertility tissue preservation study
This study, sponsored by the Oncofertiltiy Consortium, studies the removal and preservation of women’s ovarian tissue prior to chemotherapy. Early studies have shown that removed ovarian tissue remain functional after cancer treatments, and can be reinserted into a woman’s pelvis area without surgery, causing ovulation, and thus resulting in pregnancy.
3. ROVER study
This is a follow-up study to the department’s recent successful study in the area of oncology-fertility, known in the medical field as “oncofertility.” The ROVER study will demonstrate the importance and increased need of oocyte preservation for women undergoing cancer treatment who wish to preserve eggs prior to treatment, as well as for personal or age reasons. This study intends to make oocyte preservation – a relatively new option – available to all women.
4. AMIGOS study
AMGIOS (Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation) compares clomiphene citrate, Letrozole, and gonodatropin fertility treatments for women with unexplained infertility.
5. PPCOS II
PPCOS II (Pregnancy in polycystic ovary syndrome II) is a 20-week, double-blind, randomized trial of clomiphene citrate and Letrozole for the treatment of infertility in women with polycystic ovary syndrome.